AGP Picks
View all

Perspectify logo Perspectify News

Labels

Read articles from across the media landscape with news outlet bias labels for added context. Learn about labels.

Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
India’s pharma industry likely to miss 2030 sales target due to US tariff, shipping woe

India’s pharma industry likely to miss 2030 sales target due to US tariff, shipping woe

Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company

Supernus and Indivior to Merge, Forming a New CNS-Focused Pharma Company

AstraZeneca-Bristol Myers $400 Billion Merger Could Result In Biggest Pharma Company

AstraZeneca-Bristol Myers $400 Billion Merger Could Result In Biggest Pharma Company

Leading pharma company recalls eye drops in India after contamination scare | Full list of 10 products here

Leading pharma company recalls eye drops in India after contamination scare | Full list of 10 products here

Health Tech Promised Simplicity — Why Does It Feel Like More Work?

Health Tech Promised Simplicity — Why Does It Feel Like More Work?

One in 6 Deprescribed Medications Are Restarted Within 90 Days

One in 6 Deprescribed Medications Are Restarted Within 90 Days

AI to revolutionize pharma industry, says expert

AI to revolutionize pharma industry, says expert

India’s Role As ‘Pharmacy of the World’ Faces Headwinds With Trump Tariff Uncertainty

India’s Role As ‘Pharmacy of the World’ Faces Headwinds With Trump Tariff Uncertainty

<![CDATA[The Great 340B Debate]]>

<![CDATA[The Great 340B Debate]]>

<![CDATA[Pharmaceutical Executive Daily: Pathos AI Enters Two lIcensing Deals]]>

<![CDATA[Pharmaceutical Executive Daily: Pathos AI Enters Two lIcensing Deals]]>

<![CDATA[Biosimilars are driving down costs and increasing access to biologics]]>

<![CDATA[Biosimilars are driving down costs and increasing access to biologics]]>

<![CDATA[FDA grants tentative approval to new cabozantinib capsule formulation ]]>

<![CDATA[FDA grants tentative approval to new cabozantinib capsule formulation ]]>

Qubit’s Q007-302 shows promise for breast cancer

Qubit’s Q007-302 shows promise for breast cancer

Curium acquiring fellow radiopharma firm Lantheus for potential $8B

Curium acquiring fellow radiopharma firm Lantheus for potential $8B

Sibeprenlimab (Voyxact) Stabilizes Kidney Function in IgAN

Sibeprenlimab (Voyxact) Stabilizes Kidney Function in IgAN

<![CDATA[Inside Pharma's Patent Battleground: The Policy Changes Reshaping Generic and Biosimilar Competition]]>

<![CDATA[Inside Pharma's Patent Battleground: The Policy Changes Reshaping Generic and Biosimilar Competition]]>

Workforce Augmentation Through AI: Closing the Talent Gap Without Adding Headcount

Workforce Augmentation Through AI: Closing the Talent Gap Without Adding Headcount

Is automated quality inspection easier than you think?

Is automated quality inspection easier than you think?

Chia Tai Tianqing Pharmaceutical Group details new antibody-drug conjugates

Chia Tai Tianqing Pharmaceutical Group details new antibody-drug conjugates

Pregnancy- and lactation-associated osteoporosis: New statement provides practical guidance

Pregnancy- and lactation-associated osteoporosis: New statement provides practical guidance

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.